Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Jakavi 15 mg tablet:
Jakavi 15 mg tablet is used in the treatment of chronic idiopathic myelofibrosis and Polycythemia Vera.
Jakavi 15 mg Tablet can be taken regardless of food, but try to have it at the same time every day to maximize its benefits. Your physician will determine the necessary dosage and frequency of intake based on your condition, which may change over time. It is crucial to take it exactly as prescribed by your doctor. Misuse or overconsumption can lead to serious side effects. It may take several weeks or months for you to notice or feel the benefits, but do not stop taking it unless advised by your doctor.
Uses of Jakavi 15 mg tablet:
Polycythemia Vera
Chronic idiopathic myelofibrosis
Benefits of Jakavi 15 mg tablet:
In Polycythemia Vera:
Jakavi 15 mg Tablet inhibits the growth of cancer cells and prevents the proliferation of cancer cells. It is an effective but highly potent medication, and you should discuss the risks and benefits with your physician. Avoiding alcohol or smoking while undergoing this treatment and staying hydrated by drinking plenty of water are essential precautions.
In Chronic idiopathic myelofibrosis:
Jakavi 15 mg Tablet inhibits the growth of cancer cells and prevents the proliferation of cancer cells. You may experience some troublesome side effects, so discuss any concerns with your physician.
Mechanism of action of Jakavi 15 mg tablet:
Jakavi 15 mg Tablet is an anti-cancer medicine. It works by blocking the abnormal protein that signals cancer cells to multiply. This helps to halt or slow the spread of cancer cells.